Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients

Summary

Although statins reduce cardiac events in hypertensive patients with cardiovascular risk factors, the effect of statins on coronary flow reserve (CFR) has not been examined in such patients. The investigators hypothesize that pitavastatin added to standard antihypertensive therapy will be superior to placebo in improving CFR in hypertensive patients with cardiovascular risk, and try to examine this hypothesis in a double-blind, randomized comparison study using Doppler echocardiography.

Timeline

Start

2014-05

Primary completion

2016-10

Completion

2016-10

Drugs

Indications